A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses.

Nat Commun · 2021 · PMC7822889 · PMID 33483491

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The group receiving 50 μg RBD-SpyVLP showed a trend of slightly higher antibody response than the other two groups until the day of boost (day 28) (Fig. 4a ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.